---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-271006"
form_type: "8-K"
ticker: "FLGT"
cik: "0001674930"
company_name: "Fulgent Genetics, Inc."
filed_at: "2025-11-07T23:59:59+00:00"
generated_at: "2026-05-16T23:05:25.462994+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Fulgent Genetics Q3 revenue $84.1M (+17% YoY), raises FY guidance, non-GAAP EPS $0.14

## Summary
- Revenue $84.1M, up 17% YoY; raised full-year 2025 revenue guidance to $325.0M.
- GAAP net loss $6.6M ($0.21/share); non-GAAP net income $4.5M ($0.14/share).
- Full-year EPS guidance raised: GAAP loss ~($1.70)/share, non-GAAP income $0.30/share.
- Adjusted EBITDA $0.7M; GAAP gross margin 42.2%, non-GAAP 44.3%.
- Cash and short-term investments $787.7M at quarter end.

## SEC filing metadata
- accession: 0001193125-25-271006
- form_type: 8-K
- ticker: FLGT
- cik: 0001674930
- company_name: Fulgent Genetics, Inc.
- filed_at: 2025-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1674930/000119312525271006/0001193125-25-271006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1674930/000119312525271006/flgt-20251107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-271006
- JSON: https://secwatch.observer/filing/0001193125-25-271006.json
- Plain text: https://secwatch.observer/filing/0001193125-25-271006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.